Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-12 Sale | 2026-06-15 7:57 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 2,584 | $2.232 | $5,767 | 605,092 (Indirect Direct) | View |
| 2026-06-12 Sale | 2026-06-15 7:56 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 1,654 | $2.232 | $3,692 | 505,094 (Direct) | View |
| 2026-06-08 Sale | 2026-06-09 4:10 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 524 | $2.111 | $1,106 | 607,676 (Indirect Direct) | View |
| 2026-06-08 Sale | 2026-06-09 4:10 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 249 | $2.111 | $526 | 506,748 (Direct) | View |
| 2026-05-04 Sale | 2026-05-06 5:27 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 264 | $2.341 | $618 | 506,997 (Direct) | View |
| 2026-03-12 Sale | 2026-03-16 4:04 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 7,043 | $2.549 | $17,953 | 507,261 (Direct) | View |
| 2026-03-12 Sale | 2026-03-16 4:03 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 10,076 | $2.549 | $25,684 | 608,200 (Indirect Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:11 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 479 | $2.536 | $1,215 | 618,276 (Indirect Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:10 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 247 | $2.536 | $626 | 514,304 (Direct) | View |
| 2026-02-03 Sale | 2026-02-05 4:14 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 323 | $1.822 | $589 | 514,551 (Direct) | View |
| 2025-12-22 Purchase | 2025-12-29 4:52 pm | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 58,060 | $0.8483 | $49,252 | 1,055,784 (Indirect Direct) | View |
| 2025-12-12 Purchase | 2025-12-16 6:38 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 52,000 | $0.5837 | $30,352 | 3,322,990 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:34 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 257 | $0.532 | $137 | 404,874 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:34 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 526 | $0.532 | $280 | 483,755 (Indirect Direct) | View |
| 2025-11-20 Sale | 2025-11-24 4:05 pm | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 5,462 | $0.501 | $2,736 | 997,724 (Indirect Direct) | View |
| 2025-11-19 Purchase | 2025-11-20 6:02 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 35,000 | $0.4951 | $17,329 | 3,271,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-11 Tax Withholding | 2026-06-15 7:55 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 13,849 | $2.24 | 3,665,474 (Direct) | View |
| 2026-06-11 Tax Withholding | 2026-06-15 7:54 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 358 | $2.24 | 1,186,019 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 5:08 pm | N/A 2036-06-11 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 5:07 pm | N/A 2036-06-11 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 5:06 pm | N/A 2036-06-11 | Century Therapeutics Inc. | IPSC | Murphy Martin Patrick Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 5:05 pm | N/A 2036-06-11 | Century Therapeutics Inc. | IPSC | Lee Han Myung Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 5:05 pm | N/A 2036-06-11 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 74,000 | $0 | 74,000 (Direct) | View |
| 2026-06-05 Tax Withholding | 2026-06-09 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 463 | $2.13 | 3,679,323 (Direct) | View |
| 2026-05-15 Tax Withholding | 2026-05-19 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 31,172 | $2.34 | 3,679,786 (Direct) | View |
| 2025-12-09 Option Award | 2026-04-10 5:07 pm | N/A 2035-12-09 | Century Therapeutics Inc. | IPSC | Murphy Martin Patrick Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2026-04-01 Tax Withholding | 2026-04-03 7:18 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 1,365 | $2.19 | 1,186,377 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 4:07 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 55,397 | $2.73 | 3,710,958 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 4:05 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 1,431 | $2.73 | 1,187,742 (Direct) | View |
| 2026-03-06 Tax Withholding | 2026-03-10 7:53 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 463 | $2.56 | 3,766,355 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-18 5:12 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 31,172 | $1.75 | 3,766,818 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:22 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 1,420,000 | $0 | 4,742,990 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:19 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 400,000 | $0 | 883,755 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:15 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 400,000 | $0 | 1,454,173 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:12 pm | N/A 2036-02-02 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 335,000 | $0 | 739,874 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-06 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 1,611 | $0.995 | 1,054,173 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:16 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 463 | $0.526 | 3,270,990 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-11 6:04 pm | N/A 2035-12-09 | Century Therapeutics Inc. | IPSC | Lee Han Myung Director | 88,000 | $0 | 88,000 (Direct) | View |